GO:0031297 replication fork processing: DNA Damage Response Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031297 replication fork processing describes how a stalled DNA replication fork is restored to a functional state so that replication can restart.
• Fork stalling can be triggered by DNA damage, DNA secondary structures, bound proteins, dNTP shortage, or other replication obstacles.
• Key molecular events include fork reversal/regression, nascent strand degradation, checkpoint activation, and recombination-mediated restart.
• Central proteins include PARP1, BRCA1/2, RAD51, ATR, ATM, and the MRE11-RAD50-NBS1 complex, which coordinate fork protection and restart.
• Defective replication fork processing is linked to cancer predisposition, chemoresistance, and genome instability.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect replication fork processing genes.
Description
Replication fork processing (GO:0031297) is the biological process that restores a stalled DNA replication fork to a functional state and restarts DNA synthesis. Every cell must duplicate its genome accurately, but replication forks frequently encounter obstacles such as DNA lesions, secondary structures, tightly bound proteins, or nucleotide depletion. When a fork stalls, the cell activates a coordinated response that includes checkpoint signaling, fork remodeling, and recombination-mediated restart. Failure to properly process stalled forks leads to fork collapse, DNA double-strand breaks, and genome instability. Understanding replication fork processing is central to cancer biology, because many tumor suppressors and oncogenes function in this pathway. For example, BRCA1 and BRCA2 protect stalled forks from degradation, and their loss creates sensitivity to PARP inhibitors and platinum drugs. Similarly, the cGAS-STING pathway has been shown to protect stressed replication forks through calcium signaling, linking innate immune sensing to fork stability. Researchers study replication fork processing using a combination of genetic, biochemical, and imaging approaches. CRISPR-based models allow precise manipulation of candidate genes, enabling causal tests of fork protection and restart. This article summarizes the definition, mechanism, key genes, disease links, and research methods for GO:0031297, with all facts supported by peer-reviewed literature.
replication fork processing At A Glance
| GO ID | GO:0031297 |
|---|---|
| GO term | replication fork processing |
| Ontology | biological_process |
| Synonym | replication fork restart; replication restart; recovery from replication fork stalling; collapsed replication fork processing |
| Major function | Restores stalled replication forks to a functional state and restarts DNA synthesis |
| Triggering causes | DNA damage, DNA secondary structure, bound proteins, dNTP shortage, or other replication obstacles |
| Key molecular events | Fork reversal/regression, nascent strand degradation, checkpoint activation, recombination-mediated restart |
| Representative proteins | PARP1, BRCA1, BRCA2, RAD51, ATR, ATM, MRE11-RAD50-NBS1 |
| Disease relevance | Cancer predisposition, chemoresistance, genome instability |
What Is GO:0031297?
According to the Gene Ontology, GO:0031297 replication fork processing is the process in which a DNA replication fork that has stalled is restored to a functional state and replication is restarted. The stalling may be due to DNA damage, DNA secondary structure, bound proteins, dNTP shortage, or other causes. In other words, it is the cell's recovery program that detects a paused fork, stabilizes it, and re-initiates DNA synthesis.
Why Is replication fork processing Important in Cell Biology?
Replication fork processing is essential for maintaining genome integrity during every cell cycle. When forks stall and are not properly processed, they can collapse into DNA double-strand breaks, leading to mutations, chromosomal rearrangements, and cell death. This process is also a major determinant of sensitivity to chemotherapy and radiotherapy, because many anticancer agents stall replication forks. Consequently, understanding GO:0031297 has direct implications for cancer biology, drug development, and precision medicine.
• Prevents fork collapse and DNA double-strand breaks, preserving genome stability.
• Coordinates checkpoint signaling with recombination-mediated restart.
• Determines sensitivity to PARP inhibitors, platinum drugs, and other replication-targeting agents.
• Links innate immune sensing (cGAS-STING) to fork protection under stress.
• Involves tumor suppressors such as BRCA1/2, whose loss drives hereditary cancers.
• Requires PARP1 auto-modification for faithful Okazaki fragment processing and fork speed control.
• Is conserved from bacteria to humans, enabling model-organism studies.
• Provides mechanistic insights into chemoresistance and potential therapeutic targets.
What Happens During replication fork processing?
Fork stalling and detection
In simple terms: The replication machinery hits a roadblock and pauses.
Replication forks stall when they encounter DNA damage, secondary structures, bound proteins, or dNTP shortage. The stalling is detected by checkpoint kinases such as ATR and ATM, which initiate a signaling cascade to stabilize the fork and delay cell cycle progression. In bacteria, similar processing occurs at stalled forks, highlighting evolutionary conservation.
Fork reversal and regression
In simple terms: The fork can reverse direction to protect the damaged end.
Stalled forks often undergo reversal or regression, a process in which the nascent strands unwind and re-anneal to form a chicken-foot structure. This remodeling is regulated by proteins such as RAD51, SMARCAL1, and ZRANB3, and helps prevent fork collapse. Fork reversal can also expose nascent DNA to degradation by nucleases like MRE11, which is tightly controlled.
Nascent strand degradation and protection
In simple terms: The newly made DNA can be chewed back, but protective proteins stop excessive degradation.
Replication fork uncoupling causes nascent strand degradation and fork reversal. BRCA1 and BRCA2 protect stalled forks from excessive MRE11-mediated degradation, and their loss leads to fork instability. PARP1 auto-modification also promotes faithful Okazaki fragment processing and limits replication fork speed, linking PARP1 to fork protection.
Checkpoint and recombination-mediated restart
In simple terms: The cell uses repair proteins to restart the fork and finish replication.
Checkpoint kinases coordinate with homologous recombination factors such as RAD51 to restart replication. The MRE11-RAD50-NBS1 complex resects DNA ends and promotes recombination-mediated restart. In Bacillus subtilis, stalled fork processing involves recombination and restart pathways that serve as a model for understanding bacterial replication fork recovery.
Cytosolic DNA sensing and calcium signaling
In simple terms: Stressed forks can trigger immune sensors that help protect them.
Cytosolic DNA sensing by cGAS/STING promotes TRPV2-mediated Ca2+ release to protect stressed replication forks. This pathway links innate immune signaling to fork stability, revealing an unexpected role for cGAS-STING in replication fork processing.
Key Genes Involved in GO:0031297 replication fork processing
The following genes and proteins are central to replication fork processing (GO:0031297), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PARP1 | Auto-modification promotes Okazaki fragment processing and limits fork speed | Target for PARP inhibitors; CRISPR KO studies of fork speed |
| BRCA1 | Protects stalled forks from degradation; promotes restart | Hereditary breast/ovarian cancer; drug sensitivity |
| BRCA2 | Stabilizes stalled forks and prevents MRE11-mediated degradation | Cancer predisposition; PARP inhibitor response |
| RAD51 | Mediates homologous recombination and fork restart | Chemoresistance; CRISPR KO affects fork recovery |
| ATR | Checkpoint kinase that stabilizes stalled forks | Cancer therapy target; regulates fork processing |
| ATM | DNA damage checkpoint kinase involved in fork stabilization | Ataxia-telangiectasia; radiosensitivity |
| MRE11 | Resects DNA ends; degrades nascent strands at reversed forks | Cancer; fork degradation studies |
| RAD50 | Part of MRN complex; promotes recombination-mediated restart | Genome stability; CRISPR models |
| NBS1 | Part of MRN complex; recruits ATM to stalled forks | Nijmegen breakage syndrome |
| SMARCAL1 | Fork reversal/remodeling enzyme | Schimke immuno-osseous dysplasia; fork reversal |
| ZRANB3 | Fork remodeling and reversal | Genome stability; CRISPR KO |
| cGAS | Senses cytosolic DNA and protects stressed forks via STING | Innate immunity; fork protection |
| STING | Mediates cGAS signaling to protect forks | Immune signaling; fork stability |
| TRPV2 | Calcium channel mediating Ca2+ release for fork protection | Fork protection; calcium signaling |
| DNA2 | Nuclease/helicase involved in Okazaki fragment processing | Fork processing; CRISPR studies |
| FEN1 | Flap endonuclease in Okazaki fragment maturation | Fork processing; genome stability |
| PCNA | Sliding clamp; coordinates fork processing | Replication and repair; CRISPR tagging |
| RPA | Single-stranded DNA binding protein; protects ssDNA at stalled forks | Fork stability; imaging studies |
How Is replication fork processing Regulated?
Replication fork processing is regulated by checkpoint kinases (ATR, ATM), which phosphorylate downstream effectors to stabilize forks and delay cell cycle progression. PARP1 auto-modification regulates Okazaki fragment processing and fork speed. The cGAS-STING-TRPV2-Ca2+ axis protects stressed forks, linking innate immune signaling to fork stability. In bacteria, fork processing is regulated by recombination and restart pathways.
replication fork processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Hereditary breast/ovarian cancer; fork degradation | CRISPR KO in cancer cell lines; point mutation |
| BRCA2 | Hereditary breast/ovarian cancer; fork protection | Knock-in of patient mutations; KO |
| RAD51 | Chemoresistance; genome instability | Overexpression; point mutation |
| cGAS | Innate immune signaling; fork protection | KO; tagged knock-in for imaging |
| MRE11 | Cancer; fork degradation | KO; point mutation |
Cancer predisposition and genome instability
Defects in replication fork processing genes such as BRCA1, BRCA2, and RAD51 cause genome instability and predispose to breast, ovarian, and other cancers. Loss of fork protection leads to MRE11-mediated degradation and chemosensitivity.
Chemoresistance and therapy response
Tumors with altered fork processing can become resistant to PARP inhibitors and platinum drugs. Understanding fork restart mechanisms helps predict therapy response and design combination treatments.
Innate immune signaling and inflammation
cGAS-STING-mediated sensing of stressed forks protects them via TRPV2 and Ca2+ release. Dysregulation of this pathway may contribute to inflammatory diseases and autoimmunity.
From replication fork processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X protect stalled forks from degradation? | CRISPR knockout cell lines |
| Does a patient-derived point mutation impair fork restart? | Point-mutation knock-in |
| Where does protein X localize at stalled forks? | Tagged knock-in (e.g., GFP) |
| Does overexpression of gene X enhance fork speed? | Overexpression cell models |
| Which genes are essential for fork processing? | CRISPR library screening |
| How does cGAS-STING regulate fork protection? | KO and overexpression of cGAS/STING |
How to Study the replication fork processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DNA fiber assay | Fork progression, stalling, restart | CRISPR KO/point mutant cells |
| Western blot | Checkpoint kinase activation | Drug treatment; gene KO |
| RAD51 foci | Homologous recombination at stalled forks | Fork restart studies |
| Proteomics | Fork-associated proteins and modifications | Interactome mapping |
| Live-cell imaging | Fork dynamics in real time | Tagged knock-in models |
| CRISPR library screening | Essential genes for fork processing | Genome-wide screens |
| Electron microscopy | Fork reversal structures | In vitro reconstitution |
| Comet assay | DNA breaks after fork collapse | Genotoxicity studies |
DNA fiber assays
DNA fiber assays measure replication fork progression, stalling, and restart by labeling nascent DNA with nucleotide analogs. They are widely used to study fork processing defects in CRISPR-modified cells.
Checkpoint and recombination assays
Western blotting for phosphorylated ATR/ATM substrates and RAD51 foci formation assesses checkpoint activation and recombination-mediated restart. These methods are applied to cells with gene knockouts or point mutations.
Proteomics and interactomics
Mass spectrometry-based proteomics identifies proteins recruited to stalled forks and their post-translational modifications, such as PARP1 auto-modification. This helps define the fork processing interactome.
Live-cell imaging
Fluorescently tagged replication proteins (e.g., PCNA, RPA) allow real-time visualization of fork stalling and restart in living cells. Tagged knock-in models are essential for these studies.
How CRISPR Can Be Used to Study GO:0031297 replication fork processing
Knockout
CRISPR knockout of genes such as BRCA1, BRCA2, or PARP1 allows researchers to test their requirement for fork protection and restart. Knockout cell lines show increased fork degradation and sensitivity to replication stress.
Point Mutation
Point-mutation knock-in models replicate patient-derived mutations in fork processing genes, enabling precise structure-function studies. For example, mutations in BRCA2 that impair RAD51 binding can be modeled to assess fork protection.
Knock-in
Tagged knock-in of replication proteins (e.g., GFP-PCNA) enables live-cell imaging of fork dynamics and protein localization at stalled forks. This approach is valuable for studying real-time fork processing.
Overexpression
Overexpression of fork protection factors such as cGAS or STING can enhance fork stability and reveal gain-of-function phenotypes. Overexpression models are also used to study PARP1 auto-modification and fork speed.
How EDITGENE Supports replication fork processing Research
Researchers studying replication fork processing-related genes often need to determine whether a candidate gene is causally involved in fork protection, restart, or genome stability. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for replication fork processing research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SMARCAL1 Knockout Huh-7 Cell Line | EDJ-KQ46 | Human | 50485 | Details Get a Quote |
| SMARCAL1 Knockout HEK293 Cell Line | EDJ-KQ2082 | Human | 50485 | Details Get a Quote |
| WRN Knockout HEK293 Cell Line | EDJ-KQ2857 | Human | 7486 | Details Get a Quote |
| CUL4B Knockout HEK293 Cell Line | EDJ-KQ3120 | Human | 8450 | Details Get a Quote |
| CUL4A Knockout HEK293 Cell Line | EDJ-KQ3301 | Human | 8451 | Details Get a Quote |
| RECQL Knockout HEK293 Cell Line | EDJ-KQ3698 | Human | 5965 | Details Get a Quote |
| DDX11 Knockout HEK293 Cell Line | EDJ-KQ4436 | Human | 1663 | Details Get a Quote |
| CENPX Knockout HEK293 Cell Line | EDJ-KQ4785 | Human | 201254 | Details Get a Quote |
| PRIMPOL Knockout HEK293 Cell Line | EDJ-KQ5011 | Human | 201973 | Details Get a Quote |
| SETMAR Knockout HEK293 Cell Line | EDJ-KQ5737 | Human | 6419 | Details Get a Quote |
| POLQ Knockout HEK293 Cell Line | EDC90479 | Human | 10721 | Details Get a Quote |
| ASF1A Knockout HEK293 Cell Line | EDJ-KQ8258 | Human | 25842 | Details Get a Quote |
| EME1 Knockout HEK293 Cell Line | EDJ-KQ9815 | Human | 146956 | Details Get a Quote |
| ZRANB3 Knockout HEK293 Cell Line | EDJ-KQ9976 | Human | 84083 | Details Get a Quote |
| FBH1 Knockout HEK293 Cell Line | EDJ-KQ10241 | Human | 84893 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About replication fork processing
What is GO:0031297 replication fork processing?
GO:0031297 is the biological process in which a stalled DNA replication fork is restored to a functional state and replication is restarted.
What causes replication fork stalling?
Fork stalling can be caused by DNA damage, DNA secondary structures, bound proteins, dNTP shortage, or other replication obstacles.
What genes are involved in replication fork processing?
Key genes include PARP1, BRCA1, BRCA2, RAD51, ATR, ATM, MRE11, RAD50, NBS1, SMARCAL1, ZRANB3, cGAS, STING, and TRPV2.
How is replication fork processing studied?
Common methods include DNA fiber assays, Western blotting for checkpoint kinases, RAD51 foci, proteomics, live-cell imaging, and CRISPR screening.
Why is replication fork processing important in cancer?
Defects in fork processing cause genome instability and influence sensitivity to PARP inhibitors and platinum drugs.
What is fork reversal?
Fork reversal is a remodeling process where the nascent strands unwind and re-anneal to form a chicken-foot structure, protecting the fork from collapse.
How does cGAS-STING protect stalled forks?
Cytosolic DNA sensing by cGAS/STING promotes TRPV2-mediated Ca2+ release to protect stressed replication forks.
What is the role of PARP1 in fork processing?
PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed.
Can CRISPR be used to study replication fork processing?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models are widely used to dissect fork processing genes.
What diseases are linked to replication fork processing defects?
Cancer predisposition, chemoresistance, and genome instability are linked to defects in fork processing genes such as BRCA1, BRCA2, and RAD51.
Conclusion
Replication fork processing (GO:0031297) is a critical genome maintenance pathway that restores stalled forks and restarts DNA synthesis. Its molecular players, including PARP1, BRCA1/2, RAD51, and the cGAS-STING-TRPV2 axis, are central to cancer biology and therapy response. CRISPR-based models and screening approaches provide powerful tools to dissect this process and identify new therapeutic targets. EDITGENE offers comprehensive CRISPR services to support research on replication fork processing, from knockout and point-mutation models to library screening and bioinformatics.
References
- 1. Burgers PMJ et al.. 2017. Eukaryotic DNA Replication Fork.. Annu Rev Biochem 86:417-438 PMID: 28301743
- 2. Adolph MB et al.. 2024. Mechanisms and regulation of replication fork reversal.. DNA Repair (Amst) 141:103731 PMID: 39089193
- 3. Elsborg JD et al.. 2025. PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed.. Mol Cell 85(19):3562-3575.e10 PMID: 41043391
- 4. Kavlashvili T et al.. 2023. Replication fork uncoupling causes nascent strand degradation and fork reversal.. Nat Struct Mol Biol 30(1):115-124 PMID: 36593312
- 5. Lambert S et al.. 2007. Arrested replication fork processing: interplay between checkpoints and recombination.. DNA Repair (Amst) 6(7):1042-61 PMID: 17412649
- 6. Li S et al.. 2023. Cytosolic DNA sensing by cGAS/STING promotes TRPV2-mediated Ca(2+) release to protect stressed replication forks.. Mol Cell 83(4):556-573.e7 PMID: 36696898
- 7. Meng X et al.. 2017. Replication fork regression and its regulation.. FEMS Yeast Res 17(1) PMID: 28011905
- 8. Carrasco B et al.. 2024. Processing of stalled replication forks in Bacillus subtilis.. FEMS Microbiol Rev 48(1) PMID: 38052445
